Roxithromycin exposure induces motoneuron malformation and behavioral deficits of zebrafish by interfering with the differentiation of motor neuron progenitor cells

Ecotoxicol Environ Saf. 2024 May:276:116327. doi: 10.1016/j.ecoenv.2024.116327. Epub 2024 Apr 15.

Abstract

Roxithromycin (ROX), a commonly used macrolide antibiotic, is extensively employed in human medicine and livestock industries. Due to its structural stability and resistance to biological degradation, ROX persists as a resilient environmental contaminant, detectable in aquatic ecosystems and food products. However, our understanding of the potential health risks to humans from continuous ROX exposure remains limited. In this study, we used the zebrafish as a vertebrate model to explore the potential developmental toxicity of early ROX exposure, particularly focusing on its effects on locomotor functionality and CaP motoneuron development. Early exposure to ROX induces marked developmental toxicity in zebrafish embryos, significantly reducing hatching rates (n=100), body lengths (n=100), and increased malformation rates (n=100). The zebrafish embryos treated with a corresponding volume of DMSO (0.1%, v/v) served as vehicle controls (veh). Moreover, ROX exposure adversely affected the locomotive capacity of zebrafish embryos, and observations in transgenic zebrafish Tg(hb9:eGFP) revealed axonal loss in motor neurons, evident through reduced or irregular axonal lengths (n=80). Concurrently, abnormal apoptosis in ROX-exposed zebrafish embryos intensified alongside the upregulation of apoptosis-related genes (bax, bcl2, caspase-3a). Single-cell sequencing further disclosed substantial effects of ROX on genes involved in the differentiation of motor neuron progenitor cells (ngn1, olig2), axon development (cd82a, mbpa, plp1b, sema5a), and neuroimmunity (aplnrb, aplnra) in zebrafish larvae (n=30). Furthermore, the CaP motor neuron defects and behavioral deficits induced by ROX can be rescued by administering ngn1 agonist (n=80). In summary, ROX exposure leads to early-life abnormalities in zebrafish motor neurons and locomotor behavior by hindering the differentiation of motor neuron progenitor cells and inducing abnormal apoptosis.

Keywords: Locomotory behavior; Motoneuron development; Roxithromycin; Zebrafish.

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Anti-Bacterial Agents / toxicity
  • Apoptosis / drug effects
  • Behavior, Animal / drug effects
  • Cell Differentiation* / drug effects
  • Embryo, Nonmammalian / drug effects
  • Locomotion / drug effects
  • Motor Neurons* / drug effects
  • Motor Neurons* / pathology
  • Stem Cells / drug effects
  • Water Pollutants, Chemical / toxicity
  • Zebrafish*

Substances

  • Water Pollutants, Chemical
  • Anti-Bacterial Agents